BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND MUC16, CA125, CA-125 AND Diagnosis
33 results:

  • 1. Thoracic Gorham-Stout disease masquerading as an ovarian malignancy: a differential diagnosis in non-malignant causes of raised ca-125 and overview of this rare pathology.
    Sattar A; Smyth S; Soleymani Majd H
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414336
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Successful pregnancy via in vitro fertilization in a primary infertile woman with primary lymphoma of the fallopian tube after surgery: A case report and literature review.
    Zhang J; Hou Z; Huang J; Xu W; Wang C; Ma X; Lu N; Liu J; Mao Y; Qian Y
    Medicine (Baltimore); 2022 Jul; 101(30):e29353. PubMed ID: 35905233
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients.
    Klotz DM; Link T; Goeckenjan M; Wimberger P; Poetsch AR; Jaschke N; Hofbauer LC; Göbel A; Rachner TD; Kuhlmann JD
    Clin Chem Lab Med; 2022 Jan; 60(1):109-117. PubMed ID: 34687595
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Skeletal system as a rare metastatic site in patients with ovarian carcinoma.
    Ak N; Minareci Y; Saip P
    Int J Gynecol Cancer; 2021 Aug; 31(8):1125-1131. PubMed ID: 33962997
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
    Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Serum ProGRP as a novel biomarker of bone metastasis in prostate cancer.
    Yu M; Yang C; Wang S; Zeng Y; Chen Z; Feng N; Ning C; Wang L; Xue L; Zhang Z
    Clin Chim Acta; 2020 Nov; 510():437-441. PubMed ID: 32791134
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The diagnostic value of serum tumor markers CEA, CA19-9, ca125, CA15-3, and TPS in metastatic breast cancer.
    Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
    Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Waldenström's macroglobulinemia masquerading as ovarian cancer with peritoneal carcinomatosis, ascites, and elevated ca-125.
    Eulitt P; Fabian D; Kelly C; Hemminger J; William BM
    Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):54-59. PubMed ID: 28390215
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Could mucin 16 and colony-stimulating factor 2-receptor beta possible graft versus host disease biomarkers? Medical hypotheses.
    Souza MM; de Paula FM; Hsieh R; Macedo MC; Corral MA; Nunes TB; De Paula F; Lourenço SV
    Med Hypotheses; 2017 Mar; 100():89-93. PubMed ID: 28236856
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical significance of bone marrow morphological examination and tumor marker detection for lymphoma diagnosis and prognosis].
    Kang HY; Wang Y; Jin SY; Li MY; Pan YL; Liu GX; Feng XQ; Wang CB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):416-9. PubMed ID: 25948196
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer.
    Nakanishi T; Aoki D; Watanabe Y; Ando Y; Tomotsugu N; Sato Y; Saito T
    Jpn J Clin Oncol; 2015 May; 45(5):422-6. PubMed ID: 25670764
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Adenoid squamous cell carcinoma of the oral cavity.
    Terada T
    Int J Clin Exp Pathol; 2012; 5(5):442-7. PubMed ID: 22808297
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
    Molina R; Bosch X; Auge JM; Filella X; Escudero JM; Molina V; Solé M; López-Soto A
    Tumour Biol; 2012 Apr; 33(2):463-74. PubMed ID: 22161237
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy.
    Aktas B; Kasimir-Bauer S; Heubner M; Kimmig R; Wimberger P
    Int J Gynecol Cancer; 2011 Jul; 21(5):822-30. PubMed ID: 21613958
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tumor markers AFP, CA 125, and CA 19-9 in the long-term follow-up of sacrococcygeal teratomas in infancy and childhood.
    Pauniaho SL; Tatti O; Lahdenne P; Lindahl H; Pakarinen M; Rintala R; Heikinheimo M
    Tumour Biol; 2010 Aug; 31(4):261-5. PubMed ID: 20361286
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. diagnosis of a previously unidentified primary site in patients with spinal metastasis: diagnostic usefulness of laboratory analysis, CT scanning and CT-guided biopsy.
    Iizuka Y; Iizuka H; Tsutsumi S; Nakagawa Y; Nakajima T; Sorimachi Y; Ara T; Nishinome M; Seki T; Takagishi K
    Eur Spine J; 2009 Oct; 18(10):1431-5. PubMed ID: 19533181
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Value of positron emission tomography-CT imaging combined with continual detection of ca125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
    Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Sister Mary Joseph's nodule as a presenting sign of internal malignancy.
    Dodiuk-Gad R; Ziv M; Loven D; Schafer J; Shani-Adir A; Dyachenko P; Rozenman D
    Skinmed; 2006; 5(5):256-8. PubMed ID: 16957443
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Intratesticular mucinous cystadenoma: immunohistochemical comparison with ovarian and colonic tissue.
    Alasio TM; Borin J; Taylor K; Bar-Chama N; Unger PD
    Arch Pathol Lab Med; 2005 Mar; 129(3):399-402. PubMed ID: 15737039
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.